Bank of Montreal
LFCR icon

Bank of Montreal’s Lifecore Biomedical LFCR Stock Holding History

Bank of Montreal’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,165
Closed -$64.8K – 4073
2024
Q2 		$64.8K Buy
+12,165
New +$72K ﹤0.01% 3375
2021
Q2 		– Sell
-718
Closed -$7K – 4366
2021
Q1 		$7K Sell
718
-3,282
-82% -$36.9K ﹤0.01% 4522
2020
Q4 		$44K Buy
4,000
+2,798
+233% +$28.9K ﹤0.01% 4017
2020
Q3 		$13K Sell
1,202
-920
-43% -$8.76K ﹤0.01% 4023
2020
Q2 		$17K Buy
+2,122
New +$21.9K ﹤0.01% 3917
2020
Q1 		– Sell
-3,263
Closed -$37K – 4415
2019
Q4 		$37K Buy
3,263
+1,122
+52% +$11.9K ﹤0.01% 3993
2019
Q3 		$23K Buy
2,141
+84
+4% +$914 ﹤0.01% 4014
2019
Q2 		$19K Buy
+2,057
New +$20.8K ﹤0.01% 4209
2019
Q1 		– Sell
-370
Closed -$4K – 4543
2018
Q4 		$4K Buy
370
+184
+99% +$2.53K ﹤0.01% 4168
2018
Q3 		$3K Sell
186
-6
-3% -$83 ﹤0.01% 4242
2018
Q2 		$3K Buy
+192
New +$2.67K ﹤0.01% 4259
2015
Q4 		– Sell
-11,928
Closed -$139K – 4328
2015
Q3 		$139K Hold
11,928
– – ﹤0.01% 2437
2015
Q2 		$172K Buy
11,928
+4,700
+65% +$67.8K ﹤0.01% 2478
2015
Q1 		$101K Sell
7,228
-2,327
-24% -$32.2K ﹤0.01% 2626
2014
Q4 		$132K Sell
9,555
-455
-5% -$5.88K ﹤0.01% 2647
2014
Q3 		$123K Sell
10,010
-749
-7% -$9.35K ﹤0.01% 2728
2014
Q2 		$134K Buy
10,759
+616
+6% +$7.25K ﹤0.01% 2688
2014
Q1 		$113K Sell
10,143
-689
-6% -$7.56K ﹤0.01% 2745
2013
Q4 		$131K Buy
10,832
+5,835
+117% +$69.7K ﹤0.01% 2423
2013
Q3 		$61K Sell
4,997
-55
-1% -$767 ﹤0.01% 2723
2013
Q2 		$67K Buy
+5,052
New +$69.9K ﹤0.01% 2589

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Montreal's LFCR Position: Q3 2024 in Review

Bank of Montreal sold out of Lifecore Biomedical (LFCR) in Q3 2024, closing a stake of 12,165 shares — an estimated $64.8K sold.

Bank of Montreal first reported a position in LFCR in Q2 2013 and held it in 21 quarters. The position peaked at $172K in Q2 2015. 82 funds tracked by Wall St. Rank hold LFCR as of Q3 2024.

  • Bank of Montreal reported no remaining Lifecore Biomedical position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 12,165 Lifecore Biomedical shares in Q3 2024, an estimated $64.8K.
  • Bank of Montreal first reported a position in Lifecore Biomedical in Q2 2013 and held it in 21 quarters.
  • Bank of Montreal's Lifecore Biomedical position peaked at $172K in Q2 2015.
  • 82 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.